VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)

Conditions:   Metastatic Colorectal Cancer;   Colorectal Neoplasms;   Colorectal Carcinoma;   Colorectal Cancer With Hepatic Metastases;   Colorectal Tumors Interventions:   Biological: VB-111;   Drug: Nivolumab Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials